Apogee Therapeutics, Inc.
NASDAQ:APGE · NASDAQ Global Market
+$1.05 today
Vol 1.69M · Avg 0.97M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+118.57%
Period High
$92.20
Period Low
$34.65
Latest
$90.38
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Centessa Pharmaceuticals plc
NASDAQ:CNTA
$6.16B
CG Oncology, Inc. Common stock
NASDAQ:CGON
$5.48B
Legend Biotech Corporation
NASDAQ:LEGN
$5.42B
Xenon Pharmaceuticals Inc.
NASDAQ:XENE
$4.24B
Celcuity Inc.
NASDAQ:CELC
$4.21B
Soleno Therapeutics, Inc.
SLNO
$2.76B
Ultragenyx Pharmaceutical Inc.
NASDAQ:RARE
$2.73B
Disc Medicine, Inc.
NASDAQ:IRON
$2.72B
Zai Lab Limited
NASDAQ:ZLAB
$2.12B
Ascentage Pharma Group International
NASDAQ:AAPG
$396.02M
What is the latest APGE filing?
The latest filing shown is 8-K dated Jun 12, 2026.
How many recent filings does APGE have?
Intrinsic Alpha currently shows 20 recent filings for APGE.
Explore More
Continue the stock analysis
Jump to another research area for this company.